These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 11181984

  • 21. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M, Lang R, Rachmani R, Lishner M.
    Arch Intern Med; 1996 Feb 12; 156(3):286-9. PubMed ID: 8572838
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan 26; 302(6770):210-6. PubMed ID: 1998761
    [Abstract] [Full Text] [Related]

  • 25. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
    Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P.
    BMJ; 1988 Oct 29; 297(6656):1092-5. PubMed ID: 2848604
    [Abstract] [Full Text] [Related]

  • 26. ACE-I and ARBs in early diabetic nephropathy.
    Mauer M, Zinman B, Gardiner R, Drummond KN, Suissa S, Donnelly SM, Strand TD, Kramer MS, Klein R, Sinaiko AR.
    J Renin Angiotensin Aldosterone Syst; 2002 Dec 29; 3(4):262-9. PubMed ID: 12584670
    [Abstract] [Full Text] [Related]

  • 27. Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes.
    Marre M, Bouhanick B, Berrut G, Gallois Y, Le Jeune JJ, Chatellier G, Menard J, Alhenc-Gelas F.
    Hypertension; 1999 Mar 29; 33(3):775-80. PubMed ID: 10082486
    [Abstract] [Full Text] [Related]

  • 28. ACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients: a 10-year prospective study.
    de Azevedo MJ, Dalmáz CA, Caramori ML, Pecis M, Esteves JF, Maia AL, Gross JL.
    J Diabetes Complications; 2002 Mar 29; 16(4):255-62. PubMed ID: 12126783
    [Abstract] [Full Text] [Related]

  • 29. ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial.
    Rossios C, Bashir T, Achison M, Adamson S, Akpan A, Aspray T, Avenell A, Band MM, Burton LA, Cvoro V, Donnan PT, Duncan GW, George J, Gordon AL, Gregson CL, Hapca A, Hume C, Jackson TA, Kerr S, Kilgour A, Masud T, McKenzie A, McKenzie E, Patel H, Pilvinyte K, Roberts HC, Sayer AA, Smith KT, Soiza RL, Steves CJ, Struthers AD, Tiwari D, Whitney J, Witham MD, Kemp PR.
    PLoS One; 2023 Mar 29; 18(10):e0292402. PubMed ID: 37862321
    [Abstract] [Full Text] [Related]

  • 30. Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes.
    Thomas MC, Jerums G, Tsalamandris C, Macisaac R, Panagiotopoulos S, Cooper ME, MDNSG Study Group.
    Kidney Int; 2005 Jun 29; 67(6):2494-9. PubMed ID: 15882297
    [Abstract] [Full Text] [Related]

  • 31. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S, Ketelslegers JM, Lambert AE.
    Clin Exp Hypertens A; 1989 Jun 29; 11 Suppl 2():545-54. PubMed ID: 2691128
    [Abstract] [Full Text] [Related]

  • 32. The albuminuric action of atrial natriuretic peptide is not modified by ACE-inhibition with perindopril in Type 2 diabetes.
    Moore KB, McKenna K, Tormey WP, McDonald D, Thompson CJ.
    Diabet Med; 2003 Sep 29; 20(9):713-6. PubMed ID: 12925049
    [Abstract] [Full Text] [Related]

  • 33. Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
    Langham RG, Kelly DJ, Gow RM, Zhang Y, Cordonnier DJ, Pinel N, Zaoui P, Gilbert RE.
    Diabetes Care; 2006 Dec 29; 29(12):2670-5. PubMed ID: 17130203
    [Abstract] [Full Text] [Related]

  • 34. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial.
    O'Hare P, Bilbous R, Mitchell T, O' Callaghan CJ, Viberti GC, Ace-Inhibitor Trial to Lower Albuminuria in Normotensive Insulin-Dependent Subjects Study Group.
    Diabetes Care; 2000 Dec 29; 23(12):1823-9. PubMed ID: 11128360
    [Abstract] [Full Text] [Related]

  • 35. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
    J Hypertens; 2006 Nov 29; 24(11):2285-92. PubMed ID: 17053552
    [Abstract] [Full Text] [Related]

  • 36. Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Hermans MP, Brichard SM, Colin I, Borgies P, Ketelslegers JM, Lambert AE.
    Am J Med; 1992 Apr 27; 92(4B):102S-107S. PubMed ID: 1580274
    [Abstract] [Full Text] [Related]

  • 37. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
    Tarnow L, Parving HH, Jacobsen P, Rossing P, Lecerf L, Poirier O, Cambien F.
    Ugeskr Laeger; 1998 Aug 17; 160(34):4886-9. PubMed ID: 9741257
    [Abstract] [Full Text] [Related]

  • 38. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
    Tereshchenko SN, Demidova IV, Kobalava ZhD, Moiseev VS.
    Ter Arkh; 2002 Aug 17; 74(4):56-8. PubMed ID: 12043242
    [Abstract] [Full Text] [Related]

  • 39. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.
    Kidney Int; 2000 Feb 17; 57(2):601-6. PubMed ID: 10652037
    [Abstract] [Full Text] [Related]

  • 40. Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes.
    Bojestig M, Karlberg BE, Lindström T, Nystrom FH.
    Diabetes Care; 2001 May 17; 24(5):919-24. PubMed ID: 11347755
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.